Literature DB >> 2571302

The dopamine receptor in adult and maturing kidney.

R A Felder1, C C Felder, G M Eisner, P A Jose.   

Abstract

Dopamine, like other neurotransmitters, exerts its biological effects by occupation of specific receptor subtypes. The dopamine receptors in the central nervous system and certain endocrine organs are classified into the D1/D2 subtypes. Outside the central nervous system, the dopamine receptors are classified into the DA1/DA2 subtypes. The D1/D2 and DA1/DA2 receptor have marked similarities and some differences, the most notable of which is the lower affinity of the DA dopamine compared with the D dopamine receptor. DA1 receptor activation increases renal blood flow (RBF); stimulation of DA1 and DA2 receptors may also increase glomerular filtration rate (GFR). DA1 agonists inhibit fluid and electrolyte transport indirectly via hemodynamic mechanisms and directly by occupation of DA1 receptors in specific nephron segments. In the proximal tubule, DA1 agonists simulate adenylate cyclase and inhibit Na+-H+ antiport activity. They also increase phospholipase C and inhibit Na+-K+-ATPase activity (presumably as a consequence of protein kinase C activation). The latter effects may be facilitated by DA2 agonists. In cortical collecting ducts, dopamine antagonizes the effects of mineralocorticoids and the hydrosomotic effect of antidiuretic hormone. It has also been suggested that DA1 may also decrease sodium transport by influencing other hormones, such as atrial natriuretic peptide. Studies of dopamine in the young are complicated because of the propensity for dopamine to stimulate alpha-adrenoceptors. Dopamine alone may actually decrease RBF in the perinatal period. In some animals, the renal vasodilatory and natriuretic effects of dopamine increase with age. Renal tubular DA1-stimulated adenylate cyclase activity increases, whereas renal tubular DA1 receptors decrease with age. Renal DA2 receptor density is greater in the fetus; after birth renal DA2 receptors do not change. Endogenous dopamine may regulate sodium excretion in the young differently than in the adult. In the adult, sodium surfeit is associated with an increase in urinary dopamine; the opposite occurs in the young. A decrease in dopamine production or blockade of dopamine receptors results in an antinatriuresis in the adult; dopamine blockade in the young results in a natriuresis. It remains to be determined whether these age-related differences in dopamine effects are due to changes in receptor DA subtype density, second messengers, and/or interaction with other receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571302     DOI: 10.1152/ajprenal.1989.257.3.F315

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  The effect of dopamine on glomerular filtration rate in normotensive, oliguric premature neonates.

Authors:  Susan K Lynch; Kevin V Lemley; Mark J Polak
Journal:  Pediatr Nephrol       Date:  2003-05-16       Impact factor: 3.714

2.  A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.

Authors:  A Grenader; D P Healy
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

Review 3.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

4.  Endocrine function of dopaminergic neurons of the whole rat brain in ontogeny: control of prolactin secretion.

Authors:  Yu Yu Saifetyarova; A Ya Sapronova; M V Ugryumov
Journal:  Dokl Biol Sci       Date:  2012-05-05

Review 5.  Molecular biology of adrenergic and dopamine receptors and the study of developmental nephrology.

Authors:  P A Jose; R A Felder; C C Felder; W Y Chan
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

6.  Localization of dopamine-1 receptors along the microdissected rat nephron.

Authors:  F Takemoto; T Satoh; H T Cohen; A I Katz
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

7.  Regional haemodynamic effects of dopamine and its prodrugs L-dopa and gludopa in the rat and in the glycerol-treated rat as a model for acute renal failure.

Authors:  J C Drieman; F J van Kan; H H Thijssen; H van Essen; J F Smits; H A Struijker Boudier
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Mechanisms of dopamine effects on Na-K-ATPase activity in Madin-Darby canine kidney (MDCK) epithelial cells.

Authors:  M Shahedi; K Laborde; S Azimi; S Hamdani; C Sachs
Journal:  Pflugers Arch       Date:  1995-04       Impact factor: 3.657

9.  Phosphorylated Mr 32,000 dopamine- and cAMP-regulated phosphoprotein inhibits Na+,K(+)-ATPase activity in renal tubule cells.

Authors:  A Aperia; J Fryckstedt; L Svensson; H C Hemmings; A C Nairn; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

10.  Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron.

Authors:  F Takemoto; H T Cohen; T Satoh; A I Katz
Journal:  Pflugers Arch       Date:  1992-07       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.